Marvin Samson

Marvin Samson is a declared insider of Antares Pharma, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 22 May 2013 to 10 January 2020, the count stands at 16 filings.

Both buying and selling appear: 2 purchases worth €69k, against 5 sales worth €1.0M. On balance, insiders were net sellers of €978k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 5 option exercises. Since January 2020: no purchases and 4 sales on the market.

Most recently, on 14 January 2020, the filings show an open-market sale worth €227 in Antares Pharma, Inc. The last purchase on record was published on 21 March 2016, which is 3,885 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.